Biosimilars LatAm – Colombia 2025

Focused on fostering greater access to biosimilars in Colombia, this forum gathers decision-makers from the pharmaceutical industry, regulatory bodies, and associations to share success stories and actionable insights. With dynamic presentations, interactive panels, and networking opportunities, the event emphasizes the strategic importance of vaccines and plasma-derived products. Discussions will cover recent regulatory advancements, strategies for self-sufficiency, and collaborations with leading institutions to build local biotech capabilities.

Key Objectives:

– Analyze recent regulatory and strategic advancements positioning Colombia on the biosimilars map, identifying areas for investment and alliances.

– Examine the role of the industry in ensuring self-sufficiency in critical medicines, exploring government incentives and integration policies. 

– Investigate training programs in advanced skills and technology transfer through partnerships with leading Latin American institutions.

Who will
you meet?

 

More than:

Participants

Companies

HCPs

Patients

Academy

Investors

Institutions

Associations

Service Providers

Government Agencies

Industry Executives from Latam

From these areas:

  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance
  • Research
  • Regulatory
  • Business Development
  • Marketing

Speaker Board 

Program at a Glance

Advanced Local Regulation: Unlocking the Potential of Biosimilars

Examine recent updates to Colombia’s regulatory framework, focusing on accelerating approval timelines and aligning with international standards to enhance market access for biosimilars.

Strategies for the Consolidation of the Biosimilars Industry: Lessons Learned from biosimilars in Eurpe tos upport biosimilar’s development in the region

Evaluate key strategic initiatives to strengthen the Colombian biosimilars sector, ensuring long-term sustainability, competitiveness, and regional leadership.

Tailored Process and Facility Design for Biopharmaceutical Production
Tangential flow filtration solutions to meet the complex and novel biologic processes

Advancements in the Tangential flow filtration technology addresses the challenges of novel biologics in terms of membrane fouling and handling shear sensitive molecules. With tailored and optimised TFF steps, we can acheive the purification and separation, with a focus on quality and yield.

Redefining the Role of Industry in LATAM’s Health Autonomy

Analyze the industry’s role in securing Colombia’s self-sufficiency in essential medicines, focusing on government incentives, policy integration, and strategic partnerships.

Data Box: Strategic Opportunities for the Local Industry
Data Box: Data Access of PDPs for Innovation and Production of Biosimilars

Assess the role of Public-Private Development Partnerships (PDPs) in fostering innovation, improving data accessibility, and enhancing local biosimilar production capabilities.

Strengthening Capacities: Education and Technology Transfer

Examine advanced training programs and institutional collaborations that drive technology transfer and capacity building in the Latin American biosimilars sector.

Full Programme in the PDF Agenda

Download Agenda

Sponsors

Sartorius

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2019, the company earned sales revenue of some 1.83 billion euros according to preliminary figures. At the end of 2019, more than 9,000 people work at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.

Proccess Filtration R&M Colombia

Technically and commercially support the country’s industrial sector. Providing knowledge and experience to the food and beverage, cosmetic and pharmaceutical industry in separation, purification and filtration processes of critical fluids, as well as water, finished product, air lines, steam and venting.

Representatives of the main brands worldwide that are leaders in filtration, separation and purification processes, the support of allies in the United States and Asia to supply the consumption and logistics chain of our clients, complying with high quality standards.

Media Partners

BioPartner UK

BioPartner UK is the independent, accredited trade organisation that supports UK international trade

Photo Gallery from Previous Events

Testimonials

Previous Forums

Keep me updated